ScripJoin us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip 's global team, in this podcast version of Five Must-Know Things. This ep
ScripIt is no longer a rare sight to see a biotech file for bankruptcy but it still raises the eyebrows when a firm established nearly 30 years ago which had a significant degree of success such as Acorda
ScripIGM Biosciences, Inc. ’s main focus has been on oncology, but it is moving beyond that with a push into infectious and autoimmune and inflammatory diseases. While oncology will likely remain its bigge
ScripGilead's Veklury Secures Full FDA Approval For Treatment Of COVID-19 Gilead Sciences, Inc. 's Veklury (remdesivir) is the first and only drug approved by the US Food and Drug Administration for the t